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Abstract
In previous studies, we characterized a new hormonal pathway involving a mitochondrial T3 receptor (p43) acting as a
mitochondrial transcription factor. In in vitro and in vivo studies, we have shown that p43 increases mitochondrial
transcription and mitochondrial biogenesis. In addition, p43 overexpression in skeletal muscle stimulates mitochondrial
respiration and induces a shift in metabolic and contractile features of muscle fibers which became more oxidative. Here
we have studied the influence of p43 overexpression in skeletal muscle of mice during aging. We report that p43
overexpression initially increased mitochondrial mass. However, after the early rise in mitochondrial DNA occurring at 2
months of age in transgenic mice, we observed a progressive decrease of mitochondrial DNA content which became 2-fold
lower at 23 months of age relatively to control animals. Moreover, p43 overexpression induced an oxidative stress
characterized by a strong increase of lipid peroxidation and protein oxidation in quadriceps muscle, although antioxidant
enzyme activities (catalase and superoxide dismutase) were stimulated. In addition, muscle atrophy became detectable at 6
months of age, probably through a stimulation of the ubiquitin proteasome pathway via two muscle-specific ubiquitin
ligases E3, Atrogin-1/MAFbx and MuRF1. Taken together, these results demonstrate that a prolonged stimulation of
mitochondrial activity induces muscle atrophy. In addition, these data underline the importance of a tight control of p43
expression and suggest that a deregulation of the direct T3 mitochondrial pathway could be one of the parameters
involved in the occurrence of sarcopenia.
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Introduction
Triiodothyronine (T3) exerts a pleiotropic influence on
development and homeostasis of the adult. In particular, this
hormone is considered as an important regulator of muscle
development. Not only does it stimulate growth by increasing the
number and diameter of muscle fibers [1,2], but it also regulates
the transition between neonatal and adult myosin isoforms [3] and
the contractile features of adult muscle fibers [4]. Thyroid
hormone acts through nuclear receptors (T3Rs) encoded by
TRa and TRb genes (NR1A1 and NR1A2 according to nuclear
hormone receptor nomenclature) [5,6]. These receptors are
ligand-dependent transcription factors that constitutively bind to
specific sequences called thyroid hormone response elements
(T3RE) located in the promoter of T3 target genes. We have
previously identified in mitochondria truncated forms of the
nuclear receptor TRa1, with molecular weights of 43 kDa (p43)
and 28 Kda [7,8]. P43 is a mitochondrial T3 receptor which
stimulates mitochondrial transcription and protein synthesis in the
presence of T3 [9]. In C2C12 cells, its overexpression stimulates
mitochondrial activity and potentiates terminal differentiation
[10,11]. More recently, in in vivo studies, we have shown that p43
overexpression in skeletal muscle increases mitochondrial tran-
scription and mitochondrial biogenesis inducing a stimulation of
mitochondrial respiration and changes in metabolic and contrac-
tile features of muscle fibers which became more oxidative [12]. In
the oxidative muscle soleus, MyHC IIa fibers were partly replaced
by type I fibers; in the oxido-glycolytic muscle quadriceps, the
frequency of MyHC IIa and IIx fibers was increased in association
with a reduction in the number of glycolytic IIb fibers. In parallel
in in vitro studies, we reported that overexpression of p43 in human
dermal fibroblasts stimulates ROS production [13]. These data
suggest that p43 overexpression in skeletal muscle could also
induce a similar event, hence inducing an oxidative stress which
might contribute to muscle wasting via proteolysis activation.
Here we report that p43 overexpression in skeletal muscle
induces an oxidative stress despite stimulation of antioxidant
enzyme activities. In addition, this oxidative stress induces skeletal
muscle atrophy detectable at 6 months of age, concomitant to a
stimulation of the ubiquitin proteasome pathway involving two
muscle-specific ubiquitin ligases E3, Atrogin-1/MAFbx [14] and
MuRF1 [15] whose expression is strongly increased.
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Influence of p43 overexpression on mitochondrial
function during aging
We have first verified that p43 was actually overexpressed
throughout the life of transgenic animals in western-blot
experiments using quadriceps muscle extracts. We confirmed that
p43 overexpression was easily detected in muscle extracts from
mouse at 2, 6, 11 and 23 months of age (Figure 1).
We then studied changes in mitochondrial activity and
mitochondrial biogenesis in skeletal muscle of 2, 6, 11 and 23
months old mice. In electron microscopy studies performed on
quadriceps muscle from 2, 6 and 11 months old mice, p43
overexpression increased mitochondrial mass and organelle size
whatever the stage (Figure 2A). In addition, we have assessed the
amount of mitochondrial DNA (mt-DNA) in this muscle, assessed
by the value of the ratio of mitochondrial ND5 gene level relatively
to nuclear 18S gene level. The ratio ND5/18S was significantly
higher in transgenic mice than in wild type mice at 2 months of
age (+81%, p,0.05), but progressively decreased during aging to
be 2-fold lower at 23 months of age (244%, p,0.001) (Figure 2B).
In gastrocnemius of control mice, we did not record any age-
related changes in complexes I and II, cytochrome oxidase (COX)
and citrate synthase (CS) maximal activity (Figure 3). P43
overexpression strongly stimulated COX activity at 2 and 6
months (p,0.01 at both stages), but this stimulation was no longer
detected in 11 and 23 months old mice (Figure 3C). Citrate
synthase activity was only increased in 2 months old transgenic
mice (+46%; p,0.01), and remained similar to that recorded in
control animals thereafter (Figure 3D). In p43 overexpressing
mice, complex I activity was higher at 6, 11 and 23 months than in
control ones (respectively p,0.001, p,0.05 and p,0.05).
However, this stimulation was not detected at 2 months
(Figure 3A). Activity of complex II, a complex including only
nuclear encoded subunits, was not modified whatever the age of
mice (Figure 3B).
Oxygen consumption was measured on isolated permeabilized
fibers from gastrocnemius muscle in 2 and 6 months old animals.
Resting respiration (V0) was assessed in the presence of complex I
(malate/pyruvate) or complex II substrates (succinate/rotenone),
and maximal ADP-stimulated respiration (Vmax) was measured
with addition of saturating ADP concentration. In the presence of
complex I substrates no significant differences were recorded
(Figure 4A) between transgenic and control mice. In the presence
of complex II substrates, an up to two-fold increase of V0 and Vmax
(+92%) respiration rate was recorded in 2-months old transgenic
mice whereas no difference remained at 6 months of age
(Figure 4B).
According to this set of data, p43 overexpression induced a
transient rise in mitochondrial biogenesis and activity detected in 2
and/or 6 months old animals, according to the parameter
measured, followed by a progressive decrease leading to values
similar (respiration, COX, CS) or even lower that recorded in
control animals (mt-DNA).
Influence of p43 overexpression on muscle oxidative
stress
To test the possibility that the p43-induced stimulation of
mitochondrial activity could lead to an oxidative stress as
previously shown in vitro [13], we assessed lipid peroxidation,
protein oxidation and antioxidant enzyme activities (superoxide
dismutase and catalase) or other markers affected by oxidative
stress (uncoupling proteins, UCP2, UCP3 mRNA) in quadriceps
muscle extracts.
Lipid peroxidation, assessed by measurement of thiobarbituric
acid-reactive substances (TBARs), increased throughout life in
controlanimals (Figure 5B). However, TBARs levels did not change
from 2 to 23 months of life in transgenic mice (Figure 5B) and
remained significantly higher than in control ones all over the first
11 months of life (respectively +102%, p,0.001; +55%, p,0.01;
+29%, p,0.05) (Figure 5A). Oxidative damage to proteins is
noticable by a decrease in protein thiols (SH groups) levels. SH
groups increased from 2 to 6 months in control animals, thus
suggesting reduced amounts of oxidized proteins in older animals
(Figure 5D). P43 overexpression abrogated this rise (Figure 5D). As
a consequence, the amounts of SH groups were lower in transgenic
mice than in control ones from 6 to 23 months of life (respectively
246%, p,0.05; 235%, p,0.01; 240%, p,0.05) (Figure 5C).
Antioxidant enzymes such as catalase and superoxide dismutase
(SOD) are recruited to counteract free radical damage. In control
animals their activity increased after 6 (SOD) or 11 months of life
(catalase) (Figure 6B and D). A similar rise was recorded for
catalase activity in p43 overexpressing mice, but this activity
remained higher than in control animals throughout life (2
months: +92%, p,0.001; 6 months: +143%, p,0.001; 11 months:
+89%, p,0.01; 23 months: +99%, p,0.01) (Figure 6A). In
contrast, in the former, no age-related changes in SOD activity
could be detected, and was only higher than in control animals 2
months after birth (+73%, p,0.01) (Figure 6C). Measurements of
Mn-SOD and Cu-Zn/SOD expression by western-blot clearly
suggested that this higher value at 2 months of age was essentially
explained by a rise in Mn-SOD expression in transgenic mice
(+65%, p,0.01) (Figure 7B).
One of the main mitochondrial adaptations to oxidative stress is
a mild uncoupling of oxidative phosphorylation that reduces the
mitochondrial production of ROS by lowering mitochondrial
membrane potential [16,17]. We found that UCP2 and UCP3
mRNAs measured by quantitative PCR were strongly induced in
quadriceps muscle extracts from 2-months old transgenic mice
relatively to control ones (respectively +137%, p,0.01; +425%,
p,0.001) (Figure 8A–B). In line with mRNA data, we showed that
UCP2-3 proteins were strongly increased in quadriceps muscle
extracts from 2-months old transgenic mice relative to controls
(respectively +176%, p,0.001) (Figure 8C). Interestingly no
difference was recorded in 6 and 23 month old animals, and a
strong reduction in UCP2 and 3 mRNA expression in p43
overexpressing mice was even recorded at 11 months of age
(respectively 290%, p,0.001 and 292%, p,0.001) (Figure 8A–
Figure 1. p43 overexpression during aging. P43 protein levels in
quadriceps muscle extracts from transgenic mice versus wild-type
animals, assessed by western-blot using an antibody raised against TRa.
50 mg of total protein extracts were analyzed.
doi:10.1371/journal.pone.0005631.g001
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protein level (248%, p,0.00) (Figure 8C).
All these data suggest that the transient initial rise in
mitochondrial activity induced by p43 overexpression led to a
long term oxidative stress despite an increase in antioxidant
enzyme activity.
P43 influence on muscle development
To assess changes in contractile features of muscle fibres occurring
during aging in control or p43 overexpressing mice, we studied the
expression of the four adult MHCs transcripts in quadriceps (oxido-
glycolytic muscle) collected from 2 and 6 months old mice. As
previously shown [12], a shift toward a slower muscle phenotype was
Figure 2. Influence of p43 overexpression during aging on mitochondrial biogenesis. (A) electron microscopy experiments from
longitudinal sections taken from quadriceps from transgenic mice (p43) and wild-type animals (WT) at 2, 6 and 11 months of age (magnification
610.000). (B) Relative mtDNA content in quadriceps muscle from transgenic mice (p43) compared to wild-type animals (WT) at 2, 6, 11 and 23
months of age (n=8 for each group with the exception of 23 month old-group where n=6). After extraction of muscle DNA, quantitative PCR
reactions were performed using ND5 for mtDNA copy estimation, and 18S for the nuclear genome. *p,0.05 and ***p,0.001. Control values at each
stage are considered as 100%, and p43 value are expressed in percent of the corresponding control value.
doi:10.1371/journal.pone.0005631.g002
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PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5631Figure 3. Influence of p43 overexpression during aging on mitochondrial activity. (A–D) Complex I (CXI), Complex II (CXII), Cytochrome
oxidase (COX), and Citrate Synthase (CS) activities in gastrocnemius muscle extracts from transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11
and 23 months of age (n=8 for each group with the exception of 23 month old-group where n=6). *p,0.05, **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0005631.g003
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MyHCIIa and IIx expression and a simultaneous decrease in
MyHCIIb expression (Figure 9). However, at 6 months of age,
expression of MyHC-I and IIx decreased in transgenic mice
(respectively 275%, p,0.001, 240%, p,0.05) (Figure 9A and
9C).In addition, though MyHCIIa transcript levels weresignificantly
higher in p43 overexpressing mice at 6 months of age, we observed a
decrease in this transcript level during aging (+467% at 2 months vs
+96% at 6 months) (Figure 9B). Lastly, MyHCIIb transcript levels
were lower in transgenic mice than in control mice at 2 and 6 months
of age (respectively 258%; p,0.05 and 269%; p,0.001)
(Figure 9D).
In control mice, muscle weight increased progressively through-
out life. This tissular growth was markedly reduced in transgenic
animals, and muscle weight was significantly reduced in
comparison to that recorded in control animals since 6 months
of life (Figure 10). More striking was the observation that p43
overexpression induced an important loss of muscle mass in older
animals (Figure 10). In addition, in 2, 6 and 11 months old
transgenic mice, we observed structural abnormalities with an
increased amount of interstitial tissue and glycogen accumulation;
we also recorded a variability in muscle fiber size and an alteration
of muscle structure (Figure 2A).
Muscle proteolysis is known to be mediated by the ubiquitin
proteasome pathway through two muscle-specific ubiquitin ligases
E3: MAFbx (muscle atrophy Fbox or atrogin-1) [14] and MuRF1,
(muscle ring finger) [15]. MAFbx and MuRF1 are critical
regulators of the enhanced proteolysis leading to muscle atrophy
in various diseases [18]. In agreement with the muscle mass loss
observed in transgenic animals, MAFbx (2 and 6 months) and
MuRF1 (2 and 11 months) expressions were significantly
enhanced relatively to control mice (Figure 11). However, no
differences remained between the two groups at a stage (23
months) where the more severe degree of sarcopenia occurred.
Muscle oxidative capacity is a crucial factor for determining
endurance and fatigue. We thus compared exercise performance
between untrained, body-weight-matched transgenic and wild-
type mice as previously described [19]. Mice were run on
Figure 4. Influence of p43 overexpression on mitochondrial respiration at 2 and 6 months of age. (A–B) Relative respiration rate in
permeabilized gastrocnemius muscle fibers from transgenic mice (p43) and wild-type animals (WT) at 2 and 6 months of age (n=5 in each group).
Respiration parameters were recorded at 25uC using an Oroboros oxygraph. Resting respiration (V0) was initiated in the presence of complex I (5 mM
malate and 5 mM pyruvate) or complex II substrates (10 mM succinate and 2.5 mM rotenone), and maximal ADP-stimulated respiration was measured
with one addition of saturating ADP concentration (1 mM)(Vmax). MP: malate and pyruvate; SR: succinate and rotenone. *p,0.05. Control values at
each stage are considered as 100%, and p43 value are expressed in percent of the corresponding control value.
doi:10.1371/journal.pone.0005631.g004
p43 and Muscle Atrophy
PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5631treadmills until exhaustion. The running time and distance
performed by control animal decreased from 2 to 6 months of
life, in parallel to a rise in muscle fatigability (Figure 12). Just at the
opposite, running time and distance performed by transgenic mice
increased during this period, whereas muscle fatigability decreased
(Figure 12). As a consequence, physical performances were
significantly improved in 6 months old-p43 overexpressing mice,
whereas they were altered in younger animals. Similarly, whereas
fatigability was higher in 2 months-old transgenic mice, it was fully
restored 4 months later.
From these results, it appears that the initial rise in
mitochondrial activity recorded in p43 overexpressing mice
induced long term consequences characterized by the occurrence
of severe sarcopenia in relation to an enhanced expression of
MAFbx and/or MuRF1 until 11 months. However, in older
animals, this proteolytic pathway seems to be deactivated, thus
suggesting that alteration of muscle protein synthesis is probably a
major explanation for the important sarcopenia recorded in 23
months old mice.
Discussion
Influence of p43 overexpression on mitochondrial
activity
We have previously shown that p43 overexpression in skeletal
muscle of 2 month old mice increases mitochondrial transcription
and mitochondrial biogenesis, hence leading to a stimulation of
mitochondrial respiration [12]. To study the influence of this
overexpression during aging, we have analyzed changes in
mitochondrial activity and biogenesis in skeletal muscle at different
ages: 2, 6, 11 and 23 months. We recorded a biphasic response of
mitochondrial activity to p43 overexpression. First, mitochondrial
biogenesis seems to be initially stimulated, as demonstrated by a
rise in mitochondrial mass clearly apparent in histological studies
(Fig. 2), in association with a transient increase in mtDNA levels.
The initial increase in COX and CS activities clearly argues also in
favour of a general stimulation of mitochondrial activity, also in
agreement with the rise in mitochondrial respiration observed in
the presence of succinate and rotenone. However, this transient
stimulation is followed by an actual impairment of the organelle
activity reflected by a decline in COX and CS activities, associated
to a decrease in mitochondrial respiration under succinate
rotenone and in mtDNA content observed from 2 or 6 months
after birth.
Several other interesting features also appears in this study.
Among them, we have shown in vivo that the maximal activity of
complex II is poorly affected by p43 overexpression. In addition,
we report here a selective increase in mitochondrial respiration
measured in the presence of complex II substrates, occurring only
in 2 months old transgenic mice. As Complex II maximal activity
was not affected in these animals, such a result suggests that p43
improves the efficiency of this complex, considered as the second
Figure 5. p43 overexpression induces a potent oxidative stress. (A–B) Concentration of the thiobarbituric acid-reactive substances (TBARS) in
quadriceps muscle from transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with the exception
of 23 month old-group where n=6). *p,0.05, **p,0.01 and ***p,0.001. (C–D) Concentration of thiol (SH-groups) in quadriceps from transgenic
mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with the exception of 23 month old-group where n=6).
*p,0.05 and **p,0.01.
doi:10.1371/journal.pone.0005631.g005
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that, despite the general increase in mitochondrial activity
occurring in these younger animals, complex I activity remains
unchanged, thus favouring the second entry of the respiratory
chain. This possibility also well agrees with the observation that
the rise in complex II-dependent respiration disappears in 6
months old animals, when maximal complex I activity is
stimulated. In this hypothesis, this could reflect an adaptative
change in response to the stimulation of the organelle activity.
Other adaptative changes are also apparent with the observation
that maximal activity of complex I displays opposite age-related
changes to that recorded for COX or CS maximal activity.
Influence of p43 overexpression on muscle oxidative
stress
In order to understand the age-related decrease in mt-DNA
content and several parameters of mitochondrial activity recorded
in transgenic mice, we tested the possibility that this event could
result from the occurrence of an oxidative stress, for the following
reasons: i) mitochondria are the major intracellular source of
Reactive oxygen species (ROS) production ; ii) in vitro, p43
overexpression stimulates mitochondrial ROS production [13]; iii)
mtDNA is a major target of ROS [20]. We found a significant rise
in TBARS levels reflecting a higher rate of lipid peroxidation in 2
to 11 month old transgenic mice compared to wild types. In
addition, we also observed a delayed decrease in protein thiols (SH
groups) levels when compared to that recorded in control animals
detected in 6 months old and older mice. This observation clearly
reflected a stronger protein oxidation rate in muscle of p43
overexpressing mice. Interestingly, this oxidative stress takes place
in spite of the induction of antioxidant defense systems.
Antioxidant enzyme activity such as catalase and superoxide
dismutase (SOD) which are up regulated against free radical
damage, were transiently (SOD in 2 month old animals) or
permanently (catalase) increased in quadriceps muscle. These
results agree well with the study of UCP expression. One of the
main adaptations of mitochondria to oxidative stress is a mild
uncoupling of oxidative phosphorylation that reduces ROS
mitochondrial production by lowering mitochondrial membrane
potential [16,17]. It has been shown that UCPs, by decreasing
mitochondrial membrane potential, might attenuate cellular
oxidative damage in some pathophysiological states leading to
increased oxidative stress such as cancer cachexia [21]. Here we
found that UCP2 and UCP3 mRNAs and proteins were strongly
increased in quadriceps muscle of 2-month old transgenic mice
relatively to control ones. These results were in line with a previous
study showing that overexpression of p43 in human dermal
fibroblasts stimulates ROS production and induced a strong
decrease of mitochondrial membrane potential [13]. An activation
of UCP2 and UCP3 gene expression associated with an increase of
catalase activity has previously been reported in atrophied
gastrocnemius muscles of tumour-bearing rats [22,23]. However,
Figure 6. p43 overexpression increases antioxidants activities. (A–B) Catalase activity in quadriceps muscle from transgenic mice (p43)
compared to wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with the exception of 23 month old-group where n=6).
(C–D) Superoxide dismutase (SOD) activity in quadriceps muscle from transgenic mice (p43) compared to wild-type animals (WT) at 2, 6, 11 and 23
months of age (n=8 for each group with the exception of 23 month old-group where n=6). **p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0005631.g006
p43 and Muscle Atrophy
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month old animals, suggesting that this protective mechanism is
not permanently triggered during a long-term oxidative stress, a
phenomenon partly explaining the progressive decline in mtDNA
content occurring during aging of p43 overexpressing mice,
despite the permanent upregulation of catalase activity.
Influence of p43 overexpression on muscle development
As previously shown [12], p43 overexpression increased the
expression of MyHC-IIa and MyHC-IIx in two different oxido-
glycolytic muscles in younger mice, but decreased MyHC-IIb
expression, thus inducing a shift toward the acquisition of a slow-
twitch muscle phenotype. Interestingly, alterations of mitochon-
drial activity occurring during aging were associated with an
important reduction in MyHC-I, IIx and IIb expression. Although
remaining higher than in control animals, MyHC-IIa expression
was significantly lower in 6 month old compared to 2 month old
trangenic mice. These results suggest that p43-induced mitochon-
drial alterations led to a general reduction in MyHC expression,
particularly MyHC-IIx. As myosins have to be considered as
quantitatively major proteins in skeletal muscle, they also suggest
that protein synthesis is altered in p43 overexpressing mice.
In agreement with the fact that oxidative stress is known to
induce muscle atrophy, p43 overexpression induces a skeletal
muscle loss detected since 6 months of age. After the initial shift in
contractile phenotype observed in younger animals, as previously
discussed, p43 overexpression clearly decreased all MyHC
expression, particularly MyHC-IIx. In addition, as type IIX and
IIB are the predominant fibers in quadriceps muscles, our data
suggest that the reduced muscle weight in transgenic mice during
aging results for its most part from the selective atrophy of fast-
glycolytic fibers.
Muscle proteolysis is known to be mediated by the ubiquitin
proteasome pathway via two muscle-specific ubiquitin ligases E3:
Atrogin-1/MAFbx and MuRF1. In particular, MuRF1 overex-
pression results in a disruption of contractile proteins by
interacting with titin [24]. Interestingly, the expression of these
two critical regulators of muscle proteolysis was increased in
quadriceps muscle of 2-months old transgenic mice compared to
controls, at a time when muscle atrophy was not detected.
Figure 7. p43 overexpression increases MnSOD activity in 2 month-old transgenic mice. (A) Cu/ZN-SOD protein levels in quadriceps
muscle extracts from transgenic mice (p43) and wild-type animals (WT), assessed by western-blot using an antibody raised against Cu/ZN-SOD. (B)
Mn-SOD protein levels in quadriceps muscle extracts from transgenic mice (p43) and wild-type animals (WT), assessed by western-blot using an
antibody raised against Mn-SOD. 50 mg of total protein extracts were analyzed. Relative protein levels were indicated. **p,0.01. Control values at
each stage are considered as 100%, and p43 value are expressed in percent of the corresponding control value.
doi:10.1371/journal.pone.0005631.g007
p43 and Muscle Atrophy
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oxidative fibers known to be more resistant to atrophy [25]. At 6
months of age, when muscle atrophy became evident, only
MAFbx expression was increased in p43 overexpressing mice.
Interestingly, age-related changes in MAFbx and MuRF1
expression in transgenic mice displayed important differences,
with predominant MAFbx overexpression in 6 month old animals,
and a specific upregulation of MuRF1 expression in older animals.
These results suggest that MAFbx and MuRF1 mRNA expression
under atrophic conditions are induced via distinct signalling
pathways. Over all, this set of data indicates that p43
overexpression induces skeletal muscle atrophy probably by
stimulating the ubiquitin proteasome pathway via two muscle-
specific ubiquitin ligases E3: MAFbx and MuRF1. However, the
observation that the more important muscle loss occurs in 23
months old transgenic animals, at a time where expression levels of
these ubiquitin ligases are restored also suggest that muscle
proteosynthesis is severely impaired.
Experiments concerning muscle functionality have provided
surprising data. Miura and co-workers have previously shown that
2-months old mice overexpressing PGC-1a ran less than wild-type
mice because these transgenic mice presented a mitochondrial
uncoupling and a marked decrease in the ATP muscle content
[26]. Interestingly, in the treadmill test, the running time and
distance performed by the 2-month old p43 overexpressing mice
were decreased compared to wild-type. In addition, we observed a
mitochondrial uncoupling attested by the strong increase of UCP2
and UCP3 expression at 2 month of age. These data suggest that
p43 overexpression in young animals by increasing uncoupled
oxidative phosphorylation caused ATP deprivation, resulting in a
reduction of exercise perfomance as described in PGC-1a
transgenic mice at the same age [26]. More surprising is the
observation that despite the fact that muscle growth is reduced in 6
months old transgenic animals relatively to that recorded in
control mice, p43 overexpression seems to improve muscle
fatigability and endurance at this stage. This point is currently
under investigation in order to study the metabolic influence of
p43 overexpression, as changes in fuel metabolism could greatly
influence animal endurance.
In conclusion, we demonstrated that p43 overexpression
transiently stimulated mitochondrial biogenesis and activity. In
turn, this influence leads to the occurrence of an oxidative stress
probably at the origin of muscle sarcopenia. Interestingly, a similar
muscle wasting has been described in mice overexpressing PGC-
1a [26]. Hence, they underline the importance of a tight control of
p43 expression and suggest that its deregulation could be involved
in some mitochondrial diseases and could be one of the parameters
involved in the occurrence of sarcopenia.
Figure 8. Influence of p43 overexpression during aging on UCP2 and UCP3 expression. (A–B) Relative mRNA expression levels of UCP2
and UCP3 in quadriceps muscle from transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with
the exception of 23 month old-group where n=6). **p,0.01 and ***p,0.001. (C) UCP2 and UCP3 protein levels in quadriceps muscle extracts from
transgenic mice (p43) and wild-type animals (WT), assessed by western-blot using an antibody raised against UCP2 and UCP3. 50 mg of total protein
extracts were analyzed. Relative protein levels were indicated. **p,0.01 and ***p,0.001. Control values at each stage are considered as 100%, and
p43 value are expressed in percent of the corresponding control value.
doi:10.1371/journal.pone.0005631.g008
p43 and Muscle Atrophy
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Animals
All animals experiments were performed according to European
directives (86/609/CEE) and approved by Comite ´ d’Ethique en
matie `re d’Expe ´rimentation Animale: Re ´gion Languedoc-Roussillon.
The transgenic mice were generated as previously described [12].
Histological analysis
Fresh muscles were immersed in a solution of 3.5% glutaral-
dehyde in phosphate buffer (0.1 M, pH 7.4) overnight at 4uC.
They were then rinced in phosphate buffer and post-fixed (1%
osmic acid, 0.8% potassium ferrocianide) for 2 h in the dark and at
room temperature. After two rinces in a phosphate buffer, muscles
were dehydrated in a graded series of ethanol solutions (30–100%).
The cells were embedded in EmBed 812 DER 736. Thin sections
(85 nm ; Leica-Reichert Ultracut E) were collected at different
levels of each block. These sections were counterstained with
uranyl acetate and lead citrate and observed using a Hitachi 7100
transmission electron microscope in the Centre de Ressources en
Imagerie Cellulaire de Montpellier (France).
Protein studies
50 mg of mitochondrial extracts or total protein extacts were
electrophoresed onto 10% SDS-Page gels and blotted onto PDVF
membranes. The presence of p43 was assessed using RHTII
antisera as previously described [7]. The presence of a-tubulin
used for normalization was assessed using a monoclonal anti-a-
tubulin (T5168, SIGMA). The presence of UCP2-3 was assessed
using a monoclonal anti-UCP2 which also detects UCP3 (sc-6525,
Santa Cruz). The presence of Cu/Zn -SOD and Mn- SOD was
assessed using antibodies respectively from Biovalley and Lab-
Figure 9. Influence of p43 overexpression on MyHC isoforms expression at 2 and 6 months of age. (A–D) Relative mRNA expression
levels of the four adult MyHC isoforms in quadriceps muscle from transgenic mice (p43) and wild-type animals (WT) at 2 and 6 months of age (n=8
each group). *p,0.05; **p,0.01, ***p,0.001. Control values at each stage are considered as 100%, and p43 value are expressed in percent of the
corresponding control value.
doi:10.1371/journal.pone.0005631.g009
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chemioluminescent Western blot procedure (ECF kit, Amersham)
and analyzed with a PhosphorImager (Molecular dynamics).
Gene expression studies
Total RNA were isolated from quadriceps muscle using the
Trizol method (invitrogen). Samples were reverse transcribed using
superScript first-Strand synthesis System (invitrogen), and quanti-
tative PCR reactions were performed on the cDNAs in the presence
of fluorescent dye (SYBR Green, Bio-Rad). The following primers
were used: UCP2 (forward, GCATTGGCCTCTACGACTCTG ;
reverse, AGCGGACCTTTACCACATCTG); UCP3 (forward,
GACCCACGGCCTTCTACAAA ; reverse, ATTCCCGCAG-
TACCTGGACTT) ; MAFbx (forward, GACTGGACTTCTC-
GACTGCC ; reverse, TCAGCCTCTGCATGATGTTC) ;
MuRF1 (forward, CAACCTGTGCCGCAAGTG; reverse,
CAACCTCGT GCCTACAAGATG) ; MyHC-I (forward,
CCTTGGCACCAATGTCCCGGCTC ; reverse, GAAGCG-
Figure 10. Body and muscle weights of wild-type and p43 transgenic male mice at 2, 6, 11 and 23 months of age. (A) Body weights
recorded in transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with the exception of 23 month
old-group where n=6). (B) Quadriceps muscle weights recorded in transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of age
(n=8 for each group with the exception of 23 month old-group where n=6). (C) Gastrocnemius muscle weights recorded in transgenic mice (p43)
and wild-type animals (WT) at 2, 6, 11 and 23 months of age (n=8 for each group with the exception of 23 month old-group where n=6). **p,0.01
and *** p,0.001.
doi:10.1371/journal.pone.0005631.g010
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CTCCGACGCCGAG; reverse, TCTGTTAGCATGAACTGG-
TAGGCG); MyHC-IIx (forward, AAGGAGCAGGACAC-
CAGCGCCCA; reverse, ATCTCTTTGGTCACTTTCCTG-
CT); MyHC-IIb (forward, GTGATTTCTCCTGTCACCTCTC;
reverse, GGAGGACCGCAAGAACGTGCTGA) and RPS9 (for-
ward, CGGCCCGGGAGCTGTTGACG ; reverse, CTGCTT-
GCGGACCCTAATGT). DNA product of the expected size was
confirmed for each primer pair. After normalization by RPS9, all
results are expressed as percent of control as means6SEM.
Student’s t-test was used to determine all p values.
Measurement of mtDNA copy number
The mtDNA content is the mtDNA copy number normalized to
the copy number of a nuclear gene. After extraction of muscle
DNA, quantitative PCR reactions were performed using ND5
(forward, GGCAGACGAACAAGACATCCGAAA; reverse,
GCTAGGCGTTTGATTGGGTT) for mtDNA copy estimation,
and 18S for the nuclear genome. All results are expressed as
percent of control as means6SEM. Student’s t-test was used to
determine all p values.
Enzymatic activities of mitochondrial complexes
Muscle enzyme activites were measured from whole gastrocne-
mius homogenates. Proteins concentration was measured using the
Bio-Rad protein assays kit. Citrate synthase activity was measured
as described [27]. Cytochrome oxidase was measured as described
[28] and expressed in mU/mg protein.
Mitochondrial respiration on isolated fibers
Saponin-permeabilized muscle fibers were prepared from
Gastrocnemius as previously described [29]. Briefly, thin fibre
bundles were excised along the fiber orientation to avoid
mechanical damage to the cells. Fibers were carefully separated
from each other using sharp-ended forceps and needles in cooled
solution A (containing in mM: CaK2EGTA 2.77, K2EGTA 7.23,
MgCl2 6.56, DTT 0.5, potassium 2-(N-morpholino) ethansulpho-
nate (K-Mes) 50, imidazole 20, taurine 20, ATP 5.3, phosphocre-
atine 15, pH 7.1 adjusted at 4uC, free Ca
2+ concentration 0.1 mM,
a condition which prevents contraction of the bundles) until
bundles of roughly 20–30 fibers were obtained with only small
areas of contact between them. Fibers were then permeabilized by
incubation in solution A supplemented with 50 mgm l
21 saponin
Figure 11. p43 overexpression increases MAFbx and MuRF1 expression. (A–B) Relative mRNA expression levels of MAFbx and MuRF1 in
quadriceps muscle from transgenic mice (p43) and wild-type animals (WT) at 2, 6, 11 and 23 months of (n=8 for each group with the exception of 23
month old-group where n=6). *p,0.05, **p,0.01 and ***p,0.001. Control values at each stage are considered as 100%, and p43 value are
expressed in percent of the corresponding control value.
doi:10.1371/journal.pone.0005631.g011
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metabolites, including trace amounts of ADP, fibres were washed
three times in respiration solution B (containing in mM:
CaK2EGTA 2.77, K2EGTA 7.23, MgCl2 1.38, DTT 0.5, K-
Mes 100, imidazole 20, taurine 20, and K2HPO4 3, pH 7.1
adjusted at 25uC, free Ca
2+ concentration 0.1 mM) supplemented
with bovine serum albumin (2 mg ml
21). Respiratory parameters
of fiber bundles (20–30 fibers) were recorded at 25uC using a
Oroboros oxygraph. Resting respiration (V0) was initiated in the
presence of complex I (5 mM malate and 5 mM pyruvate) or
complex II substrates (10 mM succinate and 2.5 mM rotenone),
and maximal ADP-stimulated respiration was measured with one
addition of saturating ADP concentration (1 mM)(Vmax).
Determination of Muscle lipid peroxidation and thiol (SH-
group) levels
The concentration of lipid peroxide was estimated by the
thiobarbituric acid-reactive substances (TBARS) method using
total extracts from quadriceps muscle as previously described [30].
The concentration of Thiol levels using total extracts from
quadriceps muscle was measured as previously described [31].
Treadmill studies
Treadmill studies were performed as previously described [19].
Prior to the exercise performance test, the mice were accustomed
to the treadmill (Bioseb) with a 5 minutes run at 7 m/min once
per day for 2 days. The exercise test regimen was 10 m/min for
the first 60 minutes, followed by 1 m/min increment increases at
15 minutes intervals. Exhaustion was defined when mice were
unable to avoid repetitive electrical shocks.
Muscle contractile studies
Animals were anesthetized with pentobarbital sodium. The
EDL (fast twitch) muscle from the right hindlimb were surgically
exposed. The excised muscles were immediately placed into a
custom-built plexigas chamber filled with Krebs-Ringer solution
[composition (in mM): NaCl 11.9, Kcl 0.5, CaCl2 0.125, MgSO4
0.1 KH2PO4 0.1, Glucose 1, NaHCO3 2.5, Mannitol 0.11]
equilibrated with 95% O2-5 %C O 2 gas and maintained at 25uC,
pH 7.4, which is optimal for maintaining the viability of the
muscles in vitro for the duration of the experimental protocol
[32,33]. Contractile properties of the EDL was assessed in vitro
according to the methods described in detail previously [33,34].
Figure 12. Influence of p43 overexpression on exercise endurance and on muscle contractile activities at 2 and 6 months of age. (A–
B) 2 and 6 month-old transgenic mice (p43) and wild-type controls (WT) with similar body weights (n=6 for each groups) were subjected to a forced
treadmill exercise test. Running distance (A) and running time (B) are indicated. (C–D) Muscle contractile studies of 2 and 6 month-old transgenic
mice (p43) and wild-type controls (WT) with similar body weights (n=6 for each groups). Po (C) and Muscle fatigue index (D) are indicated. *p,0.05,
**p,0.01 and ***p,0.001.
doi:10.1371/journal.pone.0005631.g012
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to an isotonic force transducer (model 305B, Cambridge
instruments, Aurora Scientific Inc, Ontario, Canada) and was
stimulated along its entire length with platinum wire electrodes.
Criswell et al., have previously demonstrated that this method of
stimulation results in optimal muscle stimulation, compared with
direct stimulation using stainless steel electrodes [35]. Optimal
length, i.e the length producing maximal twitch tension, was
determined. All subsequent measurements were made at optimal
length. The tension-frequency response was then determined
(701B Stimulator, Aurora Scientific Inc, Ontario, Canada) using
stimulations trains of 500-ms at frequencies of 1–100 hz. Stimulus
trains were separated by a 1 min interval. Maximal isometric
tetanic tension (Po) were then determined. Three minutes after the
tension-frequency determination, fatigue resistance was evaluated
using a low-frequency fatigue protocol of 50 hz trains of 700-ms
delivered every 2 s for 5 min [36]. After all measurements, the
muscle was removed from the bath, trimmed of connective tissue,
blotted dry and weighed on a analytical balance. Po was co-
expressed in mN or mN/mg. Muscle fatigue index (Tlim) was
defined as the time taken for a 50% reduction in maximal power
output. Values are expressed as mean6SEM. Variables were
compared between groups using analysis of variance ANOVA,
and Newmann Keuls post-hoc multiple comparison procedure
where significance was detected. Signifiance was set at p,0.05.
Statistical analyses
All results are presented as means6SEM, or as percentages.
The significance of the difference between groups was evaluated
with Student’s t-test. *p,0.05; **p,0.01; ***p,0.001. p,0.05
was considered significant.
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